Get the latest Science News and Discoveries

GLP-1 drugs like Ozempic and Wegovy lower the risk of 42 conditions

The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an assessment of how the drugs affect 175 conditions

None

Get the Android app

Or read this on New Scientist

Related news:

Fatty muscles raise the risk of serious heart disease regardless of overall body weight

How GLP-1 drugs like Ozempic and Wegovy affect risk of 175 conditions

Fatty muscles increase the risk of heart disease. Research shows that people with hidden fat in their muscles have a higher risk of death or hospitalization for heart attack or heart failure, regardless of their body mass index.

« A cosmic shape could explain the fundamental nature of the universe